Indivior PLC (LON:INDV – Get Free Report) shares crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 1,238 and traded as high as GBX 1,264. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares.
Indivior Price Performance
The stock’s 50-day moving average price is GBX 1,238 and its 200 day moving average price is GBX 1,238. The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06. The firm has a market capitalization of £1.93 billion, a price-to-earnings ratio of -1,026.48, a PEG ratio of -5.57 and a beta of 0.19.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.
Read More
- Five stocks we like better than Indivior
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
